Exhibit 107.1
Calculation of Filing Fee Tables
Form S-8
(Form Type)
Day One Biopharmaceuticals, Inc. (Exact Name of Registrant as Specified in its Charter)
Newly Registered Securities
| Security Type |
Security Class Title | Fee Calculation Rule |
Amount Registered(1) | Proposed Maximum Offering Price Per Unit(3) |
Maximum Aggregate Offering Price(3) |
Fee Rate | Amount of Registration Fee(4) | |||||||
| Equity | Common stock, par value $0.0001 per share | Rule 457(c) and Rule 457(h) | 1,000,000(2) | $19.88 | $19,880,000 | 0.00011020 | $2,190.78 | |||||||
| Total Offering Amounts | $2,190.78 | |||||||||||||
| Total Fee Offsets(5) | — | |||||||||||||
| Net Fee Due | $2,190.78 | |||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 shall cover any additional shares of common stock, $0.0001 par value per share (“Common Stock”) of Day One Biopharmaceuticals, Inc. (the “Registrant”) that become issuable in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected without the Registrant’s receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock. |
| (2) | Represents 1,000,000 shares of Common Stock authorized to be issued under the Registrant’s 2022 Equity Inducement Plan. |
| (3) | Estimated under Rules 457(c) and (h) of the Securities Act solely for the purpose of calculating the registration fee on the basis of the average of the high and low prices of the Common Stock as quoted by The Nasdaq Global Select Market on October 25, 2022. |
| (4) | Rounded up to the nearest cent. |
| (5) | The Registrant does not have any fee offsets. |